Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Any Time Laparoscopic Cholecystectomy in Moderate to Severe Acute Cholecystitis without Septic Shock

Bhavin B Vasavada*, Hardik Patel

Consultant Hepatobiliary and Liver Transplant, Shalby Hospitals, Ahmedbad, Gujarat, India

Abstract: Introduction: There is an ongoing debate over the timings of laparoscopic cholecystectomy in acute cholecystitis. Most authors recommend surgery within the first 72 hours. We offer laparoscopic cholecystectomies in every patient with acute cholecystitis regardless of the timing of presentation. Material and methods: We prospectively analyzed outcomes of our protocol of any time acute cholecystitis. We perform laparoscopic cholecystectomies within the first 24 hours of presentation to us without considering time since attack if the patient is not in septic shock where we follow survival sepsis guidelines. Results: We performed 110 laparoscopic cholecystectomies between April, 2019-March, 2020. We prefer single-dose preoperative antibiotics (third-generation cephalosporin) in all laparoscopic cholecystectomies. A total of 79 patients were having acute cholecystitis. 67 patients were having grade 2 and 12 patients were having grade 3 cholecystitis according to Tokyo guidelines. 50 patients were presented more than 72 hours after the attack. 21 patients presented more than 48 hours but less than 72 hours. 8 patients presented within 24 hours. The mean duration of the presentation was 120 hours. 5 patients presented after more than 7 days. One patient was having grade 3 cholecystitis and was having septic shock so he was managed with percutaneous cholecystostomy and according to survival sepsis, protocol and lap choly were done after 72 hours. Out of 79 patients included in the study, 2 patients were converted to open; in 3 patients we performed lap subtotal cholecystectomy due to difficult calot triangle. Out of these only 2 patients developed port site infection and 3 patients developed bilioma which was managed by percutaneous drainage. All patients were discharged the same day or the next day. Only two patients with bilioma were readmitted. Rest all of the patients had an uneventful recovery. Conclusion: There is no need to strictly follow the 72-hour time limit for laparoscopic cholecystectomy in acute cholecystitis. Any time laparoscopic cholecystectomy should be the rule inexperienced centre.

Keywords: laparoscopic cholecystectomy, acute cholecystitis, gall stone, sepsis, surgical site infection

Received September 27, 2021; Revised November 02, 2021; Accepted November 10, 2021

Citation: Bhavin B Vasavada, Hardik Patel, Any Time Laparoscopic Cholecystectomy in Moderate to Severe Acute Cholecystitis without Septic Shock. International Journal of Celiac Disease, 9 (3). 96-98. January 2021. doi:10.12691/ijcd-9-3-1

1. Introduction

Laparoscopic cholecystectomy for acute cholecystitis is the standard of care [1]. Previously it was believed that interval cholecystectomy should be standard of care in such cases, however, it has been proven by many authors that early cholecystectomy is beneficial in such cases [2,3,4,5]. However current standard practice recommends early cholecystectomy within 72 hours of presentation, in case of delayed presentation current literature supported delayed or interval cholecystectomy. In this prospective study, we have evaluated our protocol of any time cholecystectomy. We offer cholecystectomy to every case of acute cholecystitis regardless of the timing of presentation. We have evaluated conversion to open, septic complications, bilioma and bile duct injury in such patients.

2. Material and Methods

We performed 110 laparoscopic cholecystectomies between April, 2019 - March, 2020. We give a single pre-operative antibiotic to all patients who undergo laparoscopic cholecystectomy at our institute and no post-operative antibiotics. We used Tokyo guidelines 2018 to grade the severity of cholecystitis. All surgeries were done by a team of two surgeons. We perform laparoscopic cholecystectomies within the first 24 hours of presentation to us without considering time since attack if the patient is not in septic shock where we follow survival sepsis guidelines, do percutaneous cholecystostomy, and we do cholecystectomy preferably when shock recovers and risk-benefit ratio tilt towards surgery. Statistical analyses were done using SPSS version 21. (IBM). Ethical clearance was obtained from the hospital ethics committee.

3. Results

We prefer single-dose preoperative antibiotics (third-generation cephalosporin) in all laparoscopic cholecystectomies and no postoperative antibiotics. A total of 79 patients were having grade 2 or grade 3 cholecystitis. 67 patients were having grade 2 and 12 patients were having grade 3 cholecystitis. The mean ages of patients were 52 years. The median pre-operative ASA grade was 2. One patient was having grade 3 cholecystitis and was having septic shock so he was managed with percutaneous cholecystostomy and according to survival sepsis protocol. Lap cholecystectomy was done after 72 hours. Patients’ characteristics are shown in Table 1. Out of 79 patients included in the study 2 patients were converted to open which was having grade 3 cholecystitis, in 3 patients we performed laparoscopic subtotal cholecystectomy due to difficult calot triangle. Out of these only 2 patients developed port site infections with grade 3 cholecystitis and 3 patients developed bilioma which was managed by percutaneous drainage. One of them were grade 3 and one of their grade 2 cholecystitis [Table 2]. Morbidity was significantly associated with grade 3 cholecystitis according to Tokyo guidelines. (p < 0.001) [Table 3]. All patients were discharged the same day or the next day. Only three patients with bilioma were readmitted. Rest all of the patients had an uneventful recovery. The overall morbidity rate was 12.6 percent. We considered morbidity as any deviation in recovery or standard procedure in the case of laparoscopic cholecystectomy. Here we considered subtotal cholecystectomy also as a part of morbidity. There was no mortality in our study cohort. We always adhered to Tokyo guidelines to determine the grade of cholecystitis and did not consider intra operative difficulty in grading the severity of cholecystitis. The median time for symptoms of acute cholecystitis to laparoscopic cholecystectomy was 120 hours in our study. The median total hospital stay was around 3 days in our group.

Table 1. Patients characteristics

Table 2. Morbidity rates according to the grade of cholecystitis according to Tokyo guidelines

.

Table 3. Chi-square test comparing grade of cholecystitis and complication (p value < 0.0001)

4. Discussion

Laparoscopic cholecystectomy is a standard of care for acute cholecystitis [1]. While most of the authors agree about early cholecystectomy in such cases, precise timings are still debated. Most authors still prefer 72 hrs from the presentation as preferable timings for performing laparoscopic cholecystitis [2,3,4,5]. Ours is an experienced centre for laparoscopic surgery, and we by protocol perform any time laparoscopic cholecystectomy and offer laparoscopic cholecystectomy to every patient presented to us with acute cholecystitis.

Tokyo guidelines are an effective way to analyse the severity of cholecystitis. We had one patient of grade 3 acute cholecystitis according to Tokyo guidelines with septic shock as we did percutaneous cholecystostomy [6] in that patient and followed survival septic guideline for management [7] and did laparoscopic cholecystectomy as soon as septic shock recovered. Our centre being a tertiary referral centre we get most of the cases of acute cholecystitis and expected difficult cholecystectomies that explain a high number of acute cholecystitis cases compared to symptomatic cholelithiasis.

As seen in Table 2 our overall morbidity rate was 12.6 percent and the mortality rate is 0 percent. The literature describes morbidity rates of around 5 to 20 percent and mortality rates of around 0.1 percent to 0.5 percent [8,9,10]. Here also an important thing to note is we considered subtotal cholecystectomy as a part of morbidity [Table 1].

Bile leak or bilioma happened in three patients who developed biloma however none required ercp and resolved on its own. None of them developed sepsis. Bioloma rate in our study was 3.7 percent. Walker et all showed bilioma rate of 2.7 percent but their cohort involved symptomatic as well as acute cholecystitis patients [11]. Two patients developed port side infections. All those patients were having grade 3 cholecystitis. So overall surgical site infection and infectious complication rates in our series is about 2.5% [12].

The conversion rate in our series was just 2.5 percent which is significantly low than the literature describes in the case of acute cholecystitis, which is 20-25 percent. The median hospital stay in our series was 3 days which is comparable and less than published literature and significantly less than open cholecystectomy [13,14,15]. There was no bleeding complication in our series and median blood loss was 70 ml and no blood transfusion was required in any of the patients. No patient had bowel injury in our cohort.

As shown in Table 3 in our series morbidity was significantly associated with the grade of cholecystitis according to Tokyo guidelines. Johansson et al described laparoscopic cholecystectomy as a feasible option if operated within 7 days of presentation [14]. We did not have any criteria for timing in the case of laparoscopic cholecystectomy for acute cholecystitis. The median time of presentation to surgery in our cohort was 120 hrs. And highest time was 15 days since the start of symptoms.

One patient in which we had done percutaneous cholecystostomy due to septic shock we took the patient for laparoscopic cholecystectomy as soon as shock recovered and the patient had an uneventful course in case of laparoscopic cholecystectomy. There are certain limitations to the study as it is not a randomised control trial. Biases related to the prospective study will remain in this cohort. This study still have a limited number of patients may be further randomized control trial with larger numbers are needed.

In conclusion, any time laparoscopic cholecystectomy is a feasible and safe option in case of acute cholecystitis in experienced centres without increasing morbidity and is beneficial to patients.

References

[1]   | Coccolini F, Catena F, Pisano M, Gheza F, Fagiuoli S, Di Saverio S et al. Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis. Int J Surg. 2015 Jun; 18: 196-204.
[2]   | C M Lo, C L Liu, S T Fan, E C Lai J Wong. Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg. 1998 Apr; 227(4): 461-467.
[3]   | Rutledge D, Jones D, Rege R. Consequences of delay in surgical treatment of biliary disease. Am J Surg. 2000 Dec;180(6):466-9
[4]   | Uchiyama K, Onishi H, Tani M, Kinoshita H, Ueno M, Yamaue H. Timing of laparoscopic cholecystectomy for acute cholecystitis with cholecystolithiasis. Hepatogastroenterology. 2004 Mar-Apr; 51(56): 346-8.
[5]   | Gurusamy KS¹, Samraj K. Early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Cochrane Database Syst Rev. 2006 Oct 18; (4).
[6]   | Hsieh YC, Chen CK, Su CW, Chan CC, Huo TI, Liu CJ, et al. Outcome after percutaneous cholecystostomy for acute cholecystitis: a single-center experience. J Gastrointest Surg. 2012 Oct; 16(10): 1860-8.
[7]   | Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R6 Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017 Mar; 43(3): 304-377.
[8]   | Morgenstern L, Wong L, Berci G. Twelve hundred open cholecystectomies before the laparoscopic era. A standard for comparison. Arch Surg. 1992 Apr; 127(4): 400-3.
[9]   | Chen AY, Daley J, Pappas TN, Henderson WG, Khuri SF. Growing use of laparoscopic cholecystectomy in the national Veterans Affairs Surgical Risk Study: effects on volume, patient selection, and selected outcomes. Ann Surg. 1998 Jan; 227(1): 12-24.
[10]   | Lillemoe KD, Melton GB, Cameron JL, Pitt HA, Campbell KA, Talamini MA et al. Postoperative bile duct strictures: management and outcome in the 1990s.Ann Surg. 2000 Sep; 232(3): 430-41.
[11]   | Walker AT, Shapiro AW, Brooks DC, Braver JM, Tumeh SS. Bile duct disruption and biloma after laparoscopic cholecystectomy: imaging evaluation. AJR Am J Roentgenol. 1992 Apr; 158(4): 785-9.
[12]   | Bogdanic B, Bosnjak Z, Budimir A, Augustin G, Milosevic M, Plecko V, et al. Surveillance of surgical site infection after cholecystectomy using the hospital in Europe link for infection control through surveillance protocol. Surg Infect (Larchmt). 2013 Jun; 14(3): 283-7.
[13]   | Kolla SB, Aggarwal S, Kumar A, Kumar R, Chumber S, Parshad R, et al. Early versus delayed laparoscopic cholecystectomy for acute cholecystitis: a prospective randomized trial. Surg Endosc. 2004 Sep; 18(9): 1323-7.
[14]   | Johansson M, Thune A, Blomqvist A, Nelvin L, Lundell L. Management of acute cholecystitis in the laparoscopic era: results of a prospective, randomized clinical trial. J Gastrointest Surg. 2003 Jul-Aug; 7(5): 642-5.
[15]   | Chandler CF, Lane JS, Ferguson P, Thompson JE, Ashley SW. Prospective evaluation of early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Am Surg. 2000 Sep; 66(9): 896-900.